Company news
Biote Corp. news in 2023
Biote Corp.'s news releases, calls and decks from 2023, newest first.
Biote Reports Third Quarter 2023 Financial Results
November 6, 2023
Biote Schedules Third Quarter 2023 Financial Results Release and Conference Call
October 23, 2023
Biote Reports Second Quarter 2023 Financial Results
August 9, 2023
Biote Schedules Second Quarter 2023 Financial Results Release and Conference Call
July 26, 2023
Biote Formalizes Commitment to Men’s Hormone Health With Launch of New Men’s Health Division
June 21, 2023
Biote Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to Warrants
June 7, 2023
Biote Announces Pricing of Secondary Offering of Common Stock
June 4, 2023
Biote to Participate at Upcoming Investor Conferences
May 30, 2023
Biote Appoints Mary J. Puncochar as Chief Commercial Officer
May 29, 2023
Biote Reports First Quarter 2023 Financial Results
May 8, 2023
Biote Announces Commencement of Exchange Offer and Consent Solicitation Relating to Warrants
May 8, 2023
Biote Schedules First Quarter 2023 Financial Results Release and Conference Call
April 25, 2023
Biote Names John Denne as General Manager, Men’s Health Division
April 9, 2023
Biote Reports Fourth Quarter and Full Year 2022 Financial Results
March 27, 2023
Study: Testosterone Pellet Therapy Significantly Improves Bone Density in Male Patient Case Report
March 26, 2023
Biote to Present at 35th Annual Roth Conference
March 1, 2023
Biote Schedules Fourth Quarter and Full Year 2022 Financial Results Release and Conference Call
February 8, 2023
Biote Announces Closing of Secondary Offering of 8,500,000 Shares of Common Stock Including Full Exercise of the Underwriters’ Over-Allotment Option
January 8, 2023